The age distribution of the number of incident cases (A), the number of deaths (B), and the number of DALYs (C) from 1990 to 2021, by global regions and the five SDI regions. حسب Wei-Xian Zhang (14625837)

Fig 3 - حسب Claire Gauquelin Des Pallieres (15333248)

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. حسب Jiefeng Zhao (9090305)

Cellular immune components of the pre-castration and post-castration within the tumor. حسب Nourridine Siewe (5081834)

A super-SILAC based proteomics analysis of diffuse large B-cell lymphoma-NOS patient samples to identify new proteins that discriminate GCB and non-GCB lymphomas حسب L. E. van der Meeren (7490675)

"…<div><p>Diffuse large B-cell lymphoma—not otherwise specified (DLBCL-NOS) is a large and heterogeneous subgroup of non-Hodgkin lymphoma. …"

Table_2_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf حسب Tianqi Xu (9574329)

"…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …"

Table_1_Tumor Immune Microenvironment Components and Checkpoint Molecules in Anaplastic Variant of Diffuse Large B-Cell Lymphoma.pdf حسب Tianqi Xu (9574329)

"…Background<p>Anaplastic diffuse large B-cell lymphoma(A-DLBCL) is a rare morphological subtype characterized by the presence of polygonal, bizarre-shaped tumor cells. …"

Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma حسب Wenke Wu (17665962)

"…<p>To investigate the prognostic value of lactate dehydrogenase (LDH), serum albumin (ALB) and the lactate dehydrogenase/albumin ratio (LAR) in diffuse large B-cell lymphoma (DLBCL) before primary treatment.…"

Polylactic Acid/Polybutylene Adipate Terephthalate-Carbon Nanotube Nanobiocomposites with a Segregated Toughening Morphology Yielding Large Ductility for Biocompatible Materials حسب Utsab Ayan (18552401)

Total cumulative reductions in OA-related DALYs (DALYs averted) from 8 interventions in the simulated population. حسب Jacek A. Kopec (8519922)

Example sagittal fMRI scan of a representative subject during B/S anesthesia and extracted gGM-fMRI time-course. حسب Juliana Zimmermann (10507091)

Diversity, distribution and dynamics of large trees across an old-growth lowland tropical rain forest landscape حسب David B. Clark (7846700)

Attribute DALYs of HFMD due to temperature in Guangdong, 2010–2012. حسب Zhicheng Du (3489431)

الموضوعات:

DataSheet_1_A nationwide analysis of the treatment patterns, survival, and medical costs in Korean patients with relapsed or refractory diffuse large B-cell lymphoma.docx حسب Jeong-Yeon Cho (11787386)

"…Background<p>Approximately one-third of patients with diffuse large B-cell lymphoma (DLBCL) are refractory to treatment or experience relapse after initial therapy. …"

Differential expression analysis of nuclear transcripts after siAPOBEC3A depletion reveals induction of TP53 targets and decreases in cell cycle and cell growth regulator transcrip... حسب Mason A. McCool (11889842)

Image_1_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.jpeg حسب Shengling Ma (9119243)

Image_2_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.tif حسب Shengling Ma (9119243)

<i>vFlip</i> expression largely protects from lethality induced by <i>cFlip</i> deletion. حسب Barbara Ruder (8379354)

(A) number of incidence cases by 2035; (B) projected ASR for incidence from 2035; (C) number of prevalence cases by 2035; (D) projected ASR for prevalence by 2035; (E)number of cas... حسب Junjie Chen (48472)

Image_2_Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.jpeg حسب Qikai Zhang (6905096)

"…Background<p>With the unveiling of new mechanisms and the advent of new drugs, the prognosis of diffuse large B-cell lymphoma (DLBCL) becomes promising, but some patients still progress to the relapse or refractory stage. …"